One mechanism underlying this is the ability of CXCL8 to promote melanoma cell survival via activating the phosphoinositide 3-kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK) signalling pathways, key signalling pathways involved in tumour cell survival and proliferation. Here, CXCL8 is linked to melanoma.